NEW YORK (GenomeWeb) – Alere today reported its financial results for the fourth quarter and full year ended Dec. 31, 2015, and filed its Form 10-K, which may hasten a proposed acquisition by Abbott.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.
This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.